bit.bio

bit.bio is an award-winning spinout from the University of Cambridge. Their breakthrough technology combines synthetic and stem cell biology for precise, efficient, and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. The company values science, collaboration, openness, curiosity, creativity, trust, and respect. They provide a vibrant and dynamic work environment with cutting edge technologies and a world-leading scientific advisory board, focusing on pioneering work with real-world impact. They invest in people, offering opportunities for personal development in an inclusive multi-skilled team with ambitious goals.